Wuhan Biocause Pharmaceutical Development Co L T D

FDA Filings

This page includes the latest FDA filings for Wuhan Biocause Pharmaceutical Development Co L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
Milrinone Lactate in Dextrose Hospira, Inc., Gland Pharma Limited, Wuhan Biocause Pharmaceutical Development Co., Ltd	Prescription Medication	2022-04-04
Milrinone Lactate in Dextrose Hospira, Inc., Gland Pharma Limited, Wuhan Biocause Pharmaceutical Development Co., Ltd	Prescription Medication	2021-10-22
NDC 51916-339 Wuhan Biocause Pharmaceutical Development Co., Ltd		2016-03-01
NDC 51916-308 Wuhan Biocause Pharmaceutical Development Co., Ltd		2014-08-16
NDC 51916-360 Wuhan Biocause Pharmaceutical Development Co., Ltd		2014-01-01
NDC 51916-318 Wuhan Biocause Pharmaceutical Development Co., Ltd		2012-10-16
NDC 51916-350 Wuhan Biocause Pharmaceutical Development Co., Ltd		2012-03-09
NDC 51916-314 Wuhan Biocause Pharmaceutical Development Co., Ltd		2010-10-20
NDC 51916-312 Wuhan Biocause Pharmaceutical Development Co., Ltd		2007-07-30
NDC 51916-311 Wuhan Biocause Pharmaceutical Development Co., Ltd		2007-01-02
NDC 51916-310 Wuhan Biocause Pharmaceutical Development Co., Ltd		2005-12-11
NDC 51916-323 Wuhan Biocause Pharmaceutical Development Co., Ltd		2005-10-30

Similar & Related FDA Registered Companies

• Hospira, Inc.
• Gland Pharma Limited